Sagimet Biosciences grants 63,600 stock options to two new employees

• Sagimet Biosciences granted 63,600 stock options to two newly hired employees on Oct. 28, 2026.
• The options cover Series A common stock, have a 10-year term and vest over four years.
• Vesting begins with 25% on the first anniversary of each employee's employment-based vesting commencement date.
• The remaining shares vest monthly over 36 months, subject to continued service through each vesting date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sagimet Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610290700PRIMZONEFULLFEED9855908) on October 29, 2026, and is solely responsible for the information contained therein.